Literature DB >> 2197155

Nicotine receptors in the mammalian brain.

C W Luetje1, J Patrick, P Séguéla.   

Abstract

Nicotine is a drug of abuse that presumably exerts its psychoactive effect through its interactions with nicotine binding sites in the central nervous system. Among its potential sites of action are the neuronal nicotinic acetylcholine receptors and the neuronal alpha-bungarotoxin binding sites. In this review we focus on the neuronal nicotinic acetylcholine receptors, their diversity, distribution, and functions as nicotine receptors or as mediators of synaptic transmission in the mammalian brain. We find that the complexity characteristic of the gene family encoding the subunits of these receptors is reflected both in the pattern of expression of the genes and in the pharmacological diversity of the expressed receptors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2197155     DOI: 10.1096/fasebj.4.10.2197155

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  25 in total

1.  Imaging of receptor trafficking by using alpha-bungarotoxin-binding-site-tagged receptors.

Authors:  Yoko Sekine-Aizawa; Richard L Huganir
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-24       Impact factor: 11.205

Review 2.  Nicotinic modulation of neuronal networks: from receptors to cognition.

Authors:  Huibert D Mansvelder; Karlijn I van Aerde; Jonathan J Couey; Arjen B Brussaard
Journal:  Psychopharmacology (Berl)       Date:  2005-07-02       Impact factor: 4.530

3.  Activation of muscarinic acetylcholine receptors inhibits cell cycle progression of small cell lung carcinoma.

Authors:  C L Williams; V A Lennon
Journal:  Cell Regul       Date:  1991-05

4.  Behavioural and biochemical evidence for interactions between Delta 9-tetrahydrocannabinol and nicotine.

Authors:  Emmanuel Valjent; Jennifer M Mitchell; Marie-Jo Besson; Jocelyne Caboche; Rafael Maldonado
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

5.  Quantal release at a neuronal nicotinic synapse from rat adrenal gland.

Authors:  J G Barbara; K Takeda
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

Review 6.  The main immunogenic region (MIR) of the nicotinic acetylcholine receptor and the anti-MIR antibodies.

Authors:  S J Tzartos; M T Cung; P Demange; H Loutrari; A Mamalaki; M Marraud; I Papadouli; C Sakarellos; V Tsikaris
Journal:  Mol Neurobiol       Date:  1991       Impact factor: 5.590

Review 7.  Neuronal nicotinic acetylcholine receptors as pharmacotherapeutic targets for the treatment of alcohol use disorders.

Authors:  S Chatterjee; S E Bartlett
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-03       Impact factor: 4.388

8.  Enhancement by 5-hydroxytryptamine and analogues of desensitization of neuronal and muscle nicotinic receptors expressed in Xenopus oocytes.

Authors:  K M Cross; R C Foreman; J E Chad
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

9.  Differential expression of sodium channels and nicotinic acetylcholine receptor channels in nnr variants of the PC12 pheochromocytoma cell line.

Authors:  G R Fanger; C Brennan; L P Henderson; P D Gardner; R A Maue
Journal:  J Membr Biol       Date:  1995-03       Impact factor: 1.843

10.  Developmental regulation of multiple nicotinic AChR channel subtypes in embryonic chick habenula neurons: contributions of both the alpha 2 and alpha 4 subunit genes.

Authors:  A B Brussaard; X Yang; J P Doyle; S Huck; L W Role
Journal:  Pflugers Arch       Date:  1994-11       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.